Mô tả

Summary diagram of melatonin's dual mechanism in prostate cancer: reducing intracrine androgen biosynthesis through both lipid/cholesterol depletion and direct inhibition of androgen synthesis enzymes.

Figure 25

Diagram

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 25: Summary diagram of melatonin's dual mechanism in prostate cancer: reducing intracrine androgen biosynthesis through both lipid/cholesterol depletion and direct inhibition of androgen synthesis enzymes.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Summary diagram of melatonin's dual mechanism in prostate cancer: reducing intracrine androgen biosynthesis through both lipid/cholesterol depletion and direct inhibition of androgen synthesis enzymes." />
  <figcaption>Figure 25. Summary diagram of melatonin's dual mechanism in prostate cancer: reducing intracrine androgen biosynthesis through both lipid/cholesterol depletion and direct inhibition of androgen synthesis enzymes.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

Bằng chứng liên quan

Melatonin cho Rối Loạn Nhịp Sinh Học

Xếp hạng A · 176 nghiên cứu